LIGAND PHARMACEUTICALS INCORPORATED Debt Instrument, Convertible, Carrying Amount of Equity Component
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Debt Instrument, Convertible, Carrying Amount of Equity Component of $0 as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent · last filed 2019-02-28
- 2018-12-31: Debt Instrument, Convertible, Carrying Amount of Equity Component $0.00.
- 2018-09-30: Debt Instrument, Convertible, Carrying Amount of Equity Component $0.00.
- 2018-06-30: Debt Instrument, Convertible, Carrying Amount of Equity Component $0.00.
- 2018-03-31: Debt Instrument, Convertible, Carrying Amount of Equity Component $16.08M.
| Period end | Debt Instrument, Convertible, Carrying Amount of Equity Component |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 |
| 2018-03-31 | $16.08M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $18.86M 10-K · filed 2019-02-28 |
| 2017-09-30 | $21.60M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $24.29M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $26.95M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $29.56M 10-K · filed 2018-03-01 |
| 2016-09-30 | $32.14M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $39.63M 10-K · filed 2017-02-28 |